<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01370187</url>
  </required_header>
  <id_info>
    <org_study_id>Montelukast for bronchiolitis</org_study_id>
    <nct_id>NCT01370187</nct_id>
  </id_info>
  <brief_title>Montelukast for Acute Bronchiolitis and Postbronchiolitis Viral Induced Wheezing</brief_title>
  <official_title>Montelukast for Acute Bronchiolitis and Postbronchiolitis Viral Induced Wheezing in Infants 3 to 12 Months of Age in Bandar Abbas Children' Hospital</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hormozgan University of Medical Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hormozgan University of Medical Sciences</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the current study is to evaluate the effect of Montelukast in treatment of acute
      bronchiolitis and postbronchiolitis viral induced wheezing of infants 3 to 12 months of age
      in Bandar Abbas Children' hospital.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      All the patients will be evaluated at the baseline, during hospitalization (daily) and at 2
      months and 6 months after starting the intervention.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2010</start_date>
  <completion_date type="Actual">June 2011</completion_date>
  <primary_completion_date type="Actual">April 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Respiratory Distress Severity Score (RDSS)</measure>
    <time_frame>participants will be followed for the duration of hospital stay, an expected average of 3 days</time_frame>
    <description>RDSS is measured by wheezing (0, 1, 2)+ Cough (0, 1, 2)+Retraction (0, 1,2)+Respiratory rate(0,1,2)+ Oxygen saturation(0,1,2) scores</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>average number of cough daily= as expressed parents during visits</measure>
    <time_frame>6 months</time_frame>
    <description>none= No cough, Mild=less than 10 daily, Severe=More than 10 daily</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Wheezing severity in the physical examination by physician</measure>
    <time_frame>6 Months</time_frame>
    <description>None= no wheezing, Mild= mild expiratory, Severe= inspiratory and expiratory</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">146</enrollment>
  <condition>Bronchiolitis</condition>
  <condition>Wheezing</condition>
  <condition>Cough</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Control group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Montelukast</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>4mg Montelukast daily for 2 months</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Montelukast</intervention_name>
    <description>Montelukast 4mg daily for 2 months</description>
    <arm_group_label>Montelukast</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  infant in 3-12 months of age with first episode of wheezing or bronchiolitis

          -  written informed consent by parents

        Exclusion Criteria:

          -  Previous wheezing episode or confirmed asthma or bronchiolitis

          -  recent bronchodilator use

          -  immune deficient

          -  immunosuppressive drug use

          -  croup or pneumonia diagnosis

          -  loss of follow up
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Months</minimum_age>
    <maximum_age>12 Months</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ali Asghar Parhiz, Resident</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hormzgan University of Medical Sciences (HUMS)</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hormozgan University of Medical Sciences (HUMS)</name>
      <address>
        <city>Bandar Abbas</city>
        <state>Hormozgan</state>
        <zip>79145-3388</zip>
        <country>Iran, Islamic Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Iran, Islamic Republic of</country>
  </location_countries>
  <verification_date>June 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 6, 2011</study_first_submitted>
  <study_first_submitted_qc>June 8, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 9, 2011</study_first_posted>
  <last_update_submitted>June 13, 2011</last_update_submitted>
  <last_update_submitted_qc>June 13, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 14, 2011</last_update_posted>
  <responsible_party>
    <name_title>Ali Asghar Parhiz</name_title>
    <organization>Hormozgan University of Medical Sciences (HUMS)</organization>
  </responsible_party>
  <keyword>Bronchiolitis</keyword>
  <keyword>Postbronchiolitis wheezing</keyword>
  <keyword>Montelukast</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bronchiolitis</mesh_term>
    <mesh_term>Respiratory Sounds</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Montelukast</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

